The same group tested the effects of spironolactone in 20 diabetic kidney disease patients (both type 1 and type 2 diabetes) with nephrotic range proteinuria and reported that the mean urinary albumin levels were reduced by 32% by spironolactone after 2 months [149]. Here, ALB is linked to type 2 diabetes mellitus.